Gene · 2030
Papers2,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,306
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 8-Hydroxydaidzein Induces Apoptosis and Inhibits AML-Associated Gene Expression in U-937 Cells: Potential Phytochemical for AML Treatment. | Biomolecules | 2023 | 38002257 | PubTator, text mining | PubMed |
| Editorial on the Special Issue Titled "Pathology and Diagnosis of Gynecologic Diseases". | Diagnostics (Basel) | 2023 | 37998616 | PubTator, text mining | PubMed |
| A new technique for the analysis of metabolic pathways of cytidine analogues and cytidine deaminase activities in cells. | Sci Rep | 2023 | 37993628 | PubTator, text mining | PubMed |
| Determinants of gemcitabine response in pancreatic cancer: are we there? | J Gastrointest Oncol | 2023 | 37969825 | PubTator, text mining | PubMed |
| Early enterovirus translation deficits extend viral RNA replication and elicit sustained MDA5-directed innate signaling. | mBio | 2023 | 37962360 | PubTator, text mining | PubMed |
| CamoTSS: analysis of alternative transcription start sites for cellular phenotypes and regulatory patterns from 5' scRNA-seq data. | Nat Commun | 2023 | 37945584 | PubTator, text mining | PubMed |
| Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by activating Stat1-CCL2-mediated immunity. | J Immunother Cancer | 2023 | 37935566 | PubTator, text mining | PubMed |
| Mechanisms underlying the changes in acetaldehyde dehydrogenase 1 in cholangiocarcinoma. | J Cancer | 2023 | 37928420 | PubTator, text mining | PubMed |
| Pattern recognition in the landscape of seemingly random chimeric transcripts. | Comput Struct Biotechnol J | 2023 | 37920814 | PubTator, text mining | PubMed |
| Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study. | Front Pharmacol | 2023 | 37920204 | PubTator, text mining | PubMed |
| Uptake Transporters at the Blood-Brain Barrier and Their Role in Brain Drug Disposition. | Pharmaceutics | 2023 | 37896233 | PubTator, text mining | PubMed |
| The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer's Disease. | Biomolecules | 2023 | 37892128 | PubTator, text mining | PubMed |
| The evolution of antiseizure medication therapy selection in adults: Is artificial intelligence -assisted antiseizure medication selection ready for prime time? | J Cent Nerv Syst Dis | 2023 | 37868934 | PubTator, text mining | PubMed |
| Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance. | Cancers (Basel) | 2023 | 37835408 | PubTator, text mining | PubMed |
| Possible New Histological Prognostic Index for Large B-Cell Lymphoma. | J Clin Med | 2023 | 37834968 | PubTator, text mining | PubMed |
| Force redistribution in clathrin-mediated endocytosis revealed by coiled-coil force sensors. | Sci Adv | 2023 | 37831774 | PubTator, text mining | PubMed |
| Human cellular model systems of β-thalassemia enable in-depth analysis of disease phenotype. | Nat Commun | 2023 | 37803026 | PubTator, text mining | PubMed |
| Intracellular Gemcitabine Monophosphate Levels Predict Chemotherapy Efficacy in Gemcitabine-Treated Patients with Bladder Cancer. | Dokl Biochem Biophys | 2023 | 37768422 | PubTator, text mining | PubMed |
| Brown Fat and Nutrition: Implications for Nutritional Interventions. | Nutrients | 2023 | 37764855 | PubTator, text mining | PubMed |
| Platelets and the Atherosclerotic Process: An Overview of New Markers of Platelet Activation and Reactivity, and Their Implications in Primary and Secondary Prevention. | J Clin Med | 2023 | 37763014 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2030/papers?page=8